Abstract
The aim of this mini-review is to highlight the current state of the problem of nosocomial pneumonia and nosocomial tracheobronchitis in critically ill patients. The important concepts for nosocomial tracheobronchitis, novel genetic and molecular biomarkers of nosocomial pneumonia and nosocomial tracheobronchitis and the role of inhaled antibiotics in the treatment of this condition and their ability to prevent the development of nosocomial pneumonia are discussed.
Keywords: Colistin, inhaled antibiotics, nosocomial pneumonia, nosocomial tracheobronchitis, tobramycin, respiratory tract.
Graphical Abstract